SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-14-001385
Filing Date
2014-05-09
Accepted
2014-05-09 06:35:42
Documents
9
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10q.htm 10-Q 521810
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 14154
3 EXHIBIT 32.1 ex32-1.htm EX-32.1 4472
  Complete submission text file 0001493152-14-001385.txt   4128414

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lixt-20140331.xml EX-101.INS 609443
5 XBRL SCHEMA FILE lixt-20140331.xsd EX-101.SCH 49849
6 XBRL CALCULATION FILE lixt-20140331_cal.xml EX-101.CAL 43483
7 XBRL DEFINITION FILE lixt-20140331_def.xml EX-101.DEF 140213
8 XBRL LABEL FILE lixt-20140331_lab.xml EX-101.LAB 310509
9 XBRL PRESENTATION FILE lixt-20140331_pre.xml EX-101.PRE 213868
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-51476 | Film No.: 14826954
SIC: 2834 Pharmaceutical Preparations